Literature DB >> 9064487

The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.

A J McAdams1, R P Valentini, T R Welch.   

Abstract

We performed a detailed clinical review and pathologic analysis of the kidney biopsies of 134 children with nephrotic syndrome or asymptomatic proteinuria. This analysis challenges some of our concepts about the classification of conditions associated with these disorders. The presence of focal segmental sclerotic lesions does not define a unique disorder in childhood. Some children with such lesions will have unaffected glomeruli that are ultrastructurally completely normal. These patients, predominately black adolescents, present either with nephrotic syndrome or asymptomatic proteinuria. We classify this disorder as primary focal segmental glomerulosclerosis (FSGS) and have never found it to recur after transplantation. Most other children with FSGS have 1 of 2 specific glomerulopathies. Those with minimal change have generalized fusion of podocyte foot processes. Those with mesangial proliferation have similar foot process changes combined with mesangial expansion and proliferation and, frequently, thinning of the lamina densa and tubuloreticular inclusions. The presence of segmental lesions in these glomerulopathies appears to be nothing more than a marker of severity. Children with these glomerulopathies are generally younger white children, virtually all of whom have nephrotic syndrome. These disorders have a strong propensity to recur after transplantation. The presence of mesangial labeling of IgM or C1q has no significance in any of these 3 disorders. The classification of disorders associated with nephrotic syndrome or asymptomatic proteinuria must concentrate less on the presence or absence of focal sclerosis and more on the histologic appearance of the rest of the glomeruli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9064487     DOI: 10.1097/00005792-199701000-00004

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  8 in total

1.  Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Authors:  Pietro Ravani; Alberto Magnasco; Alberto Edefonti; Luisa Murer; Rossella Rossi; Luciana Ghio; Elisa Benetti; Floriana Scozzola; Andrea Pasini; Nadia Dallera; Felice Sica; Mirco Belingheri; Francesco Scolari; Gian Marco Ghiggeri
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

2.  Primary focal segmental glomerular sclerosis in children: clinical course and prognosis.

Authors:  Kyung Hoon Paik; Bum Hee Lee; Hee Yeon Cho; Hee Gyung Kang; Il Soo Ha; Hae Il Cheong; Dong-Kyu Jin; Kyung Chul Moon; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-10-21       Impact factor: 3.714

3.  A patient with nephrotic-range proteinuria and focal global glomerulosclerosis.

Authors:  Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-25       Impact factor: 8.237

4.  Idiopathic nephrotic syndrome in Polish children - its variants and associations with HLA.

Authors:  Aleksandra Krasowska-Kwiecień; Krystyna Sancewicz-Pach; Anna Moczulska
Journal:  Pediatr Nephrol       Date:  2006-09-12       Impact factor: 3.714

5.  Primary focal segmental glomerulosclerosis in Egyptian children: a 10-year single-centre experience.

Authors:  Ahmed M El-Refaey; Ashraf Bakr; Ayman Hammad; Atef Elmougy; Fatma El-Houseeny; Ashraf Abdelrahman; Amr Sarhan
Journal:  Pediatr Nephrol       Date:  2010-03-02       Impact factor: 3.714

6.  Rituximab May Have Positive Effect on Refractory Nephrotic Syndrome: A Meta-Analysis of Randomized Trials.

Authors:  Jingjing Lin; Jia Sun
Journal:  Comput Math Methods Med       Date:  2022-06-30       Impact factor: 2.809

7.  Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis.

Authors:  Gian Marco Ghiggeri; Luca Musante; Giovanni Candiano; Maurizio Bruschi; Laura Santucci; Giancarlo Barbano; Antonella Trivelli; Lucia Rivabella; Rosanna Gusmano; Francesco Perfumo
Journal:  Pediatr Nephrol       Date:  2007-07-28       Impact factor: 3.714

8.  Rituximab in children with resistant idiopathic nephrotic syndrome.

Authors:  Alberto Magnasco; Pietro Ravani; Alberto Edefonti; Luisa Murer; Luciana Ghio; Mirco Belingheri; Elisa Benetti; Corrado Murtas; Giovanni Messina; Laura Massella; Maria Gabriella Porcellini; Michela Montagna; Mario Regazzi; Francesco Scolari; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2012-05-10       Impact factor: 10.121

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.